Detection of presymptomatic Parkinson's disease: Combining smell tests, transcranial sonography, and SPECT

2004 ◽  
Vol 19 (10) ◽  
pp. 1196-1202 ◽  
Author(s):  
Ulrike Sommer ◽  
Thomas Hummel ◽  
Katja Cormann ◽  
Antje Mueller ◽  
Johannes Frasnelli ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Transcranial Sonography ◽  
Smell Tests

P143 An objective 3D-transcranial sonography method for detecting Parkinson’s disease – A pilot study

Basal Ganglia ◽  
2011 ◽  
Vol 1 (1) ◽  
pp. 33
Author(s):  
A. Plate ◽  
A. Ahmadi ◽  
T. Klein ◽  
O. Paulyp ◽  
N. Navab ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Pilot Study ◽  
Transcranial Sonography

A baseline study for detection of Parkinson's disease with 3D-transcranial sonography and uni-lateral reconstruction

2019 ◽  
Vol 397 ◽  
pp. 16-21 ◽  
Author(s):  
Annika Plate ◽  
Juliana Maiostre ◽  
Johannes Levin ◽  
Kai Bötzel ◽  
Seyed-Ahmad Ahmadi
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Transcranial Sonography ◽  
Baseline Study

Midbrain transcranial sonography in Korean patients with Parkinson's disease

2007 ◽  
Vol 22 (13) ◽  
pp. 1922-1926 ◽  
Author(s):  
Ji Youn Kim ◽  
Seong Tae Kim ◽  
Seong Hee Jeon ◽  
Won Yong Lee
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Transcranial Sonography ◽  
Korean Patients

scholarly journals Diagnosis of Parkinson’s Disease. Part 1. The Potential of Functional Neuroimaging

Doctor Ru ◽  
2020 ◽  
Vol 19 (9) ◽  
pp. 6-12
Author(s):  
M.R. Sapronova ◽  
◽  
D.V. Dmitrenko ◽  
N.A. Schnaider ◽  
A.A. Molgachev ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Functional Neuroimaging ◽  
Single Photon ◽  
Photon Emission ◽  
Transcranial Sonography ◽  
Emission Computed Tomography ◽  
Resonance Spectroscopy ◽  
Positron Emission ◽  
Neuroimaging Techniques

Objective of the Review: To describe available functional neuroimaging techniques for use in patients with Parkinson’s disease (PD). Key Points: Parkinson’s disease is a neurodegenerative disorder which affects 2-3% of people older than 65 years. The main neuropathological hallmarks of PD are an accumulation of alpha-synuclein aggregates in the cellular cytoplasm and a loss of neurons in the pars compacta of the substantia nigra, leading to dopamine deficiency. Clinical symptoms of the disease appear when the underlying neural impairment is already advanced, which significantly reduces treatment options. Over the two last decades, functional neuroimaging techniques such as positron emission tomography, single-photon emission computed tomography, proton magnetic resonance spectroscopy, and transcranial sonography have increasingly been used for diagnosing PD during patients’ lifetime and understanding the neuropathological mechanisms and compensatory reactions underlying its symptoms, as well as for monitoring the progression of PD. Conclusion: Modern functional neuroimaging techniques not only facilitate differential diagnosis of PD, but also make it possible to detect the disease at its early/preclinical stage. Keywords: Parkinson’s disease, neuroimaging, positron emission tomography, single-photon emission computed tomography, proton magnetic resonance spectroscopy, transcranial sonography.

Sign in / Sign up

Export Citation Format

Share Document